Medication Description: Solizimum
Enzyme (lipolytic) drug derived from the culture of Pnicillium solitum.
Porous mass or powder of light brown color with a slight specific smell. Few soluble in water.
Solizim is a lipolytic enzyme. Hydrolyzes vegetable and animal fats; promotes the digestion and absorption of fats. The activity of the drug is determined by the ability to hydrolyze the emulsion of olive oil and expressed in LU (lipolytic unit).
Apply with chronic pancreatitis with low lipolytic activity, with chronic diseases of the gastrointestinal tract (achilia, gastritis, hepatitis, cholecystitis, etc.).
Is taken orally during or immediately after a meal, 40 000 LE 3 times a day. The course of treatment for 3 - 4 weeks.
Product form: tablets solizima (coated yellow) with a content of 20,000 LE, soluble in the intestine (Tabulettae Solizymi 20 000 LE of enterosolubiles), in a package of 100 pieces
Storage: in a dry, dark place at a temperature no higher than + 4 'C.